2018 ICPE Presentation: Use of Multiple Sclerosis Drugs Among Live Birth Pregnancies in the United States

Project Title 2018 ICPE Presentation: Use of Multiple Sclerosis Drugs Among Live Birth Pregnancies in the United States
Date
Thursday, August 23, 2018
Location

Use of Multiple Sclerosis Drugs Among Live Birth Pregnancies in the United States
Medical Product
alemtuzumab
daclizumab
dalfampridine
dimethyl fumarate
fingolimod
glatiramer acetate
interferon beta-1A
interferon beta-1B
mitoxantrone
natalizumab
peginterferon beta-1a
teriflunomide
Host

34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Authors

Danijela Stojanovic, Mayura Shinde, Nicole Haug, Mohamed Mohamoud, Leyla Sahin, Genna Panucci, Rajani Rajbhandari, Lockwood Taylor
Related Assessments
Abstracts of the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Prague Congress Centre, Prague, Czech Republic, August 22–26, 2018 | Abstract 63